1. Home
  2. ECOR vs SHOT Comparison

ECOR vs SHOT Comparison

Compare ECOR & SHOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • SHOT
  • Stock Information
  • Founded
  • ECOR 2005
  • SHOT 2018
  • Country
  • ECOR United States
  • SHOT United States
  • Employees
  • ECOR N/A
  • SHOT N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SHOT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ECOR Health Care
  • SHOT Health Care
  • Exchange
  • ECOR Nasdaq
  • SHOT Nasdaq
  • Market Cap
  • ECOR 40.1M
  • SHOT 33.4M
  • IPO Year
  • ECOR 2018
  • SHOT 2020
  • Fundamental
  • Price
  • ECOR $6.02
  • SHOT $0.45
  • Analyst Decision
  • ECOR Strong Buy
  • SHOT
  • Analyst Count
  • ECOR 2
  • SHOT 0
  • Target Price
  • ECOR $25.50
  • SHOT N/A
  • AVG Volume (30 Days)
  • ECOR 130.4K
  • SHOT 737.5K
  • Earning Date
  • ECOR 05-07-2025
  • SHOT 05-14-2025
  • Dividend Yield
  • ECOR N/A
  • SHOT N/A
  • EPS Growth
  • ECOR N/A
  • SHOT N/A
  • EPS
  • ECOR N/A
  • SHOT N/A
  • Revenue
  • ECOR $25,182,000.00
  • SHOT $701,967.00
  • Revenue This Year
  • ECOR $32.20
  • SHOT N/A
  • Revenue Next Year
  • ECOR $46.27
  • SHOT N/A
  • P/E Ratio
  • ECOR N/A
  • SHOT N/A
  • Revenue Growth
  • ECOR 57.09
  • SHOT 246.36
  • 52 Week Low
  • ECOR $5.02
  • SHOT $0.34
  • 52 Week High
  • ECOR $19.49
  • SHOT $2.14
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 33.07
  • SHOT 49.11
  • Support Level
  • ECOR $5.20
  • SHOT $0.36
  • Resistance Level
  • ECOR $6.47
  • SHOT $0.53
  • Average True Range (ATR)
  • ECOR 0.71
  • SHOT 0.05
  • MACD
  • ECOR 0.33
  • SHOT 0.01
  • Stochastic Oscillator
  • ECOR 49.26
  • SHOT 57.59

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About SHOT Safety Shot Inc.

Safety Shot Inc is a wellness and functional beverage company. It is set to launch Safety Shot, the patented beverage that helps people feel faster by reducing blood alcohol content and boosting clarity.

Share on Social Networks: